118 related articles for article (PubMed ID: 9581882)
1. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir.
Kiessling AA; Fitzgerald LM; Zhang D; Chhay H; Brettler D; Eyre RC; Steinberg J; McGowan K; Byrn RA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S33-41. PubMed ID: 9581882
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption.
Choudhury B; Pillay D; Taylor S; Cane PA
J Med Virol; 2002 Dec; 68(4):467-72. PubMed ID: 12376952
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.
Parera M; Ibañez A; Clotet B; Martinez MA
J Infect Dis; 2004 Apr; 189(8):1444-51. PubMed ID: 15073682
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.
Gupta P; Leroux C; Patterson BK; Kingsley L; Rinaldo C; Ding M; Chen Y; Kulka K; Buchanan W; McKeon B; Montelaro R
J Infect Dis; 2000 Jul; 182(1):79-87. PubMed ID: 10882584
[TBL] [Abstract][Full Text] [Related]
5. [The male genital tract: A host for HIV].
Le Tortorec A; Dejucq-Rainsford N
Gynecol Obstet Fertil; 2007 Dec; 35(12):1245-50. PubMed ID: 18035579
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
[TBL] [Abstract][Full Text] [Related]
7. Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir.
Byrn RA; Kiessling AA
J Reprod Immunol; 1998 Dec; 41(1-2):161-76. PubMed ID: 10213308
[TBL] [Abstract][Full Text] [Related]
8. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
[TBL] [Abstract][Full Text] [Related]
9. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.
Mayer KH; Boswell S; Goldstein R; Lo W; Xu C; Tucker L; DePasquale MP; D'Aquila R; Anderson DJ
Clin Infect Dis; 1999 Jun; 28(6):1252-9. PubMed ID: 10451162
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy.
Potter SJ; Lemey P; Achaz G; Chew CB; Vandamme AM; Dwyer DE; Saksena NK
J Leukoc Biol; 2004 Sep; 76(3):562-70. PubMed ID: 15218056
[TBL] [Abstract][Full Text] [Related]
11. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
Notermans DW; Danner SA; de Wolf F; Lange JM
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
[TBL] [Abstract][Full Text] [Related]
12. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
[TBL] [Abstract][Full Text] [Related]
14. Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV-1 RNA in blood and semen.
Chakraborty H; Helms RW; Sen PK; Cohen MS
Stat Med; 2003 May; 22(9):1457-64. PubMed ID: 12704609
[TBL] [Abstract][Full Text] [Related]
15. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
Eron JJ; Smeaton LM; Fiscus SA; Gulick RM; Currier JS; Lennox JL; D'Aquila RT; Rogers MD; Tung R; Murphy RL
J Infect Dis; 2000 May; 181(5):1622-8. PubMed ID: 10783117
[TBL] [Abstract][Full Text] [Related]
16. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing.
Garrido N; Meseguer M; Remohí J; Simón C; Pellicer A
Hum Reprod; 2005 Apr; 20(4):1028-34. PubMed ID: 15608027
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
[TBL] [Abstract][Full Text] [Related]
19. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
[TBL] [Abstract][Full Text] [Related]
20. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
